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Abstract
Purpose The most common complications of electrophysiology (EP) procedures are related to vascular access. Our study aims to
conduct a meta-analysis comparing ultrasound (US)-guided vs. palpation-based technique for femoral venous access in EP
procedures.
Methods Electronic databases were searched and systematically reviewed for studies comparing femoral vein puncture with/
without US in EP procedures. The primary outcome was the rate of major vascular complications; secondary outcomes were
minor vascular complications, inadvertent artery puncture, postprocedural groin pain, and puncture time. Predefined subgroup
analysis was conducted separately for patients undergoing pulmonary vein isolation procedure (PVI). A random-effects model
was used to derive risk ratios (RR) with 95% confidence interval (CI).
Results Nine studies involving 8232 patients met our inclusion criteria. Compared with the standard technique, the use of US
reduced major vascular complications (from 2.01 to 0.71%, p < 0.0001). The rate of minor vascular complications (RR = 0.30,
95% CI, 0.14–0.62, p = 0.001) and inadvertent artery puncture were lower with US-guided puncture (RR = 0.31, 95% CI, 0.17–
0.58, p = 0.0003). Puncture time was shorter (mean difference = − 92.1 s, 95% CI, − 142.12 – − 42.07 s, p = 0.0003) and
postprocedural groin pain was less frequent (RR = 0.57, 95% CI, 0.41–0.79, p = 0.0008) in the US group. Subgroup analysis
of patients undergoing PVI also showed significant reduction of major vascular complications (RR = 0.27, 95% CI, 0.12–0.64,
p = 0.003) and inadvertent artery puncture (RR = 0.35, 95% CI, 0.21–0.59, p < 0.0001).
Conclusion Real-time US-guidance of femoral vein puncture in EP procedures is beneficial: it reduces major and minor vascular
complications, inadvertent artery puncture, postprocedural groin pain, and puncture time.
Keywords Ultrasound-guided puncture . Electrophysiology procedures . Vascular access . Pulmonary vein isolation .
Complications
1 Background
The most common complications of electrophysiology (EP)
procedures are related to the vascular access. These may in-
terfere with the quality of life of the patients and often prolong
hospitalization [1, 2]. The rate of vascular access-related com-
plications varies depending on the definition and the type of
the procedure. Atrial fibrillation (AF) ablation carries higher
risk of vascular access complications compared with other EP
procedures [1]. This may be explained by the combination of
uninterrupted oral anticoagulation and intraprocedural sys-
temic anticoagulation to reduce the risk of thromboembolic
complications, in addition to multiple large-bore access sites
for the procedure compared with most EP procedures. This
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exposes patients undergoing AF ablation to a higher risk of
bleeding complications, ranging from 1 to 13% depending on
the cohort [1, 3–6].
Supplementing the traditional anatomy landmark-based
vascular puncture, an ultrasound (US) guidance offers poten-
tial benefits including prevention of vascular access-related
complications. Using an US-gel-filled sterile sleeve covered
vascular probe connected to a portable ultrasonograph allows
direct and real-time visualization of the inguinal region. US
may clarify the anatomy of the femoral vessels and the sur-
rounding structures and identify variations that may interfere
with the success of the puncture (Fig. 1). In addition, placing
the probe perpendicular over the inguinal region and the fem-
oral vein, it is possible to follow the needle during the punc-
ture to guide and correct its course [7]. US-guided femoral
puncture has a short learning curve and does not interfere with
the normal workflow of EP procedures [7]. Earlier studies
reported a lower rate of inadvertent arterial puncture, a higher
rate of first-pass success, and a decreased risk of complica-
tions associated with the use of US [8–10].
A previous meta-analysis of observational trials showed a
60% and 66% reduction in major and minor vascular compli-
cations using US guidance for femoral vein access in EP pro-
cedures [11]. Since this study, further important data—
including a randomized controlled trial—have been published
comparing US-guided vs. standard technique [12].
Therefore, in the present study, we aimed to extend the
earlier analyses in order to better characterize the impact of
US-guidance at cannulation of the femoral vein during EP
procedures.
2 Methods
2.1 Search strategy
Electronic databases (Medline, Excerpta Medica Database
(EMBASE), Cochrane Register of Controlled Trials
(CENTRAL), and Scopus) were searched for relevant articles
published between January 2000 and April 2019 using a
search strategy that combined text word and MeSH heading.
The search string was “vascular” and “ultrasound” or “ultra-
sonography” and “electrophysiology or electrophysiological”
or “catheter ablation.” No language restriction was used.
Furthermore, we extended the search with the reference lists
of the relevant studies and reviews, editorials, letters, and also
relevant abstracts.We performed the analyses according to the
PRISMA guideline [13].
2.2 Data abstraction and statistical analysis
Both randomized controlled and observational trials—
regardless of their prospective/retrospective design—
comparing real-time US-guided to conventional, anatom-
ical landmark and palpation-guided technique for femoral
vein puncture in EP procedures were identified. Selection
and data abstraction were done independently by two re-
viewers (P.K. and A.K.). Disagreements were resolved by
consensus.
The meta-analysis was conducted by using Review
Manager (RevMan) Version 5.3 software (Cochrane
Collaboration, London, UK). A random-effects model
was used to derive risk ratios (RR) with 95% confidence
interval (CI) on dichotomous outcomes and mean differ-
ence on continuous data. Heterogeneity was tested with a
chi square heterogeneity statistic for which a p value < 0.2
was considered potentially heterogeneous. Consistency
was assessed by the I2 statistic, which describes the per-
centage of total variation across studies that is due to het-
erogeneity rather than due to chance. Inconsistency was
described as low, moderate, and high, based on I2 values
of 25, 50, and 75%, respectively.
The primary outcome was the presence of major vascular
complications (groin hematoma, arteriovenous fistula, and
pseudoaneurysm). Hematoma was considered to be a major
vascular complication if it met type 2 or higher Bleeding
Fig. 1 Illustrative examples of
two-dimensional ultrasound im-
ages of the femoral vessels with
expected (Panel a) and unexpect-
ed (Panel b) localization. CFA
common femoral artery, CFV
common femoral vein
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Academic Research Consortium (BARC) criteria (requiring
nonsurgical, medical intervention by a health care profession-
al; leading to hospitalization or increased level of care, or
prompting evaluation) [14]. Secondary outcomes were minor
vascular complications (groin hematomas < BARC 2), inad-
vertent artery puncture, groin pain, and puncture time.
Predefined subgroup analysis was conducted separately for
patients undergoing pulmonary vein isolation (PVI) proce-
dure. The review protocol was registered in the PROSPERO
database under the registration number of CRD42019139143.
3 Results
Nine studies involving 8232 patients met our inclusion
criteria, published between 2013 and 2018. One study was
randomized and eight were observational, non-randomized
(Table 1) [12, 15–22]. The results of the literature search are
summarized in Fig. 2.
Compared with the standard technique, the use of US for
femoral vein puncture significantly reduced the rate of major
vascular complications from 2.01 to 0.71%. Calculated from
this, 71% of relative risk reduction (RR = 0.39, 95% CI, 0.17–
0.51, p < 0.0001, Fig. 3), the number needed to treat (NNT)
was approximately 77; that is, the US-guided puncture has to
be applied in 77 patients to avoid 1 major adverse event.
Risk of minor vascular complications with US guidance
showed a reduction from 1.49 to 0.45% (RR = 0.30, 95%
CI, 0.14–0.62, p = 0.001, Fig. 4). The risk of inadvertent arte-
rial puncture was reduced from 19.7 to 5.93% (RR = 0.31,
95% CI, 0.17–0.58, p = 0.0003) compared with the standard
group (Fig. 4). The time required for the puncture was shorter
(mean difference = − 92.1 s, 95% CI, − 142.12 – − 42.07 s,
p = 0.0003, Fig. 4) and groin pain was less frequent (22.22
vs. 13.04%, RR = 0.41, 95% CI, 0.41–0.79, p = 0.0008) in
the US group (Fig. 4).
Subgroup analysis of patients undergoing PVI also showed
significant reduction of major vascular complications (2.07
vs. 0.87%, RR = 0.27, 95% CI, 0.12–0.64, p = 0.003, Fig. 5)
and inadvertent artery puncture (19.28 vs. 6.52%, RR = 0.29,
95% CI, 0.17–0.50, p = 0.00001, Fig. 4). Among patients un-
dergoing catheter ablation for AF, the NNTwas 83. The eval-
uation of secondary outcomes in the subgroup analysis could
not be performed due to the lack of data.
Based on the results of Chi2 and I2 tests, the sample proved
to be homogenous and consistent, except for data regarding
inadvertent arterial puncture, where moderate inconsistency
could be detected. Funnel plot analyses showed no sign of
possible publication bias.
4 Discussion
Our meta-analysis demonstrated that the use of US guidance
for vascular access among patients undergoing EP procedures
reduces the relative risk of major vascular complications by
71% compared with the standard, anatomical landmark-
guided technique. In addition, US-guided femoral vein punc-
ture significantly reduced puncture time and improved out-
comes regarding minor vascular complications, inadvertent
arterial puncture, and postprocedural groin pain. In the sub-
group analysis of patients undergoing PVI, the rates of major
vascular complications and inadvertent artery puncture were
significantly lower in the US-guided group.
Procedures involving puncture of major vessels are in-
creasingly used in various fields of medicine. This is a tenden-
cy that besides opening possible new treatment options, it also
exposes patients to a certain risk for complications. Data from
the American Society of Anesthesiologists Closed Claims
Project database indicates that the majority of central venous
catheter placement-associated complications are vascular in-
juries [23]. In a previous review, the overall complication rate
Fig. 2 Flowchart of study
selection
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reached 15% for central venous catheterization [24]. This high
frequency is partially related to the increasing rate of interven-
tions requiring anticoagulant and antiplatelet medications, as
well as to the limitations of the conventional palpation-based
puncture technique.
The anatomical orientation points-guided puncture is con-
sidered to be the standard during femoral venous access, al-
though examining bony landmarks and femoral arterial pulsa-
tion may not be sufficient for the localization of the femoral
vein in a considerable proportion of cases. An analysis of the
inguinal region computed tomographic scans showed that the
femoral artery overlaps the femoral vein in two-thirds of the
patients [25]. These individual variations may lead to unsuc-
cessful puncture or various complications if direct visualiza-
tion is not performed.
The US-guided approach allows direct visualization of fem-
oral vessels with a higher rate of successful venous puncture.
An analysis of four studies comparing the US-guided to the
anatomical landmarks-guided technique for femoral vein can-
nulation showed that the use of US is associated with improved
success rate, however, in these reports there were no significant
differences in the complication rates, puncture time, arterial
punctures, or hematomas [10]. Guidelines for the Prevention
of Intravascular Catheter-Related Infections—developed by a
task force comprising members from the Society of Critical
Care Medicine, the Society for Healthcare Epidemiology of
America, and the American Society of Critical Care
Anesthesiologists—recommended the use of US-guidance dur-
ing central venous catheter insertions [26].
Electrophysiology procedures may represent a field where
the safety aspects of the central venous access site are of par-
amount interest. The most common major complications of
EP procedures are related to vascular access. These may re-
quire intervention and result in prolonged hospitalization [1,
27, 28]. The prevalence of these complications varies depend-
ing on the type of procedure. Vascular access-related compli-
cations have been described in 0.3–0.4% of supraventricular
tachycardia ablations [1, 29], and 0.4–4.7% of premature ven-
tricular complex/ventricular tachycardia ablations [1, 30, 31].
Patients undergoing AF ablation procedures experience a vas-
cular access complication rate of 1–13% depending on the
definition [4, 5, 32, 33].
Catheter ablation for AF not only has the most commonly
performed ablation procedure but also has specific consider-
ations regarding the vascular access complications [27, 34].
Besides the large-bore catheters and multiple access sites
used for these procedures, in order to prevent ischemic com-
plications, the recommended treatment comprises uninterrupt-
ed oral anticoagulant administration [35]. Oral and procedural
anticoagulation may augment the importance and interfere
Fig. 3 Major vascular complications. US ultrasound
Fig. 4 Summary of outcomes of secondary endpoints. AF atrial fibrillation. *Mean difference (95% CI)
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with the treatment of injuries suffered during the access and
result in more frequent bleeding complications [27].
Improving the security of the catheter ablation remains a
primary goal in electrophysiology. With a potential for easy
adaptation in the EP laboratory environment, vascular US
offers a quick and inexpensive technique with a steep learning
curve. It does not increase the duration of the procedure,
moreover—as our results showed—puncture time and thus
the skin-to-skin measured procedure time can be reduced.
For a detailed description of technical details, we refer to the
review article of Wiles et al. describing the technique of US-
guided femoral vein puncture with special regards to its appli-
cation in the EP laboratory [7, 36]. Despite the obvious ben-
efits, the routine use of US for femoral vein access has not
been widely adopted among the electrophysiologists.
In light of the fact that the number of EP procedures is
increasing, prevention of vascular access-related complica-
tions is desirable not only to improve safety outcomes but also
to reduce additional costs of the management of complications
[37]. We found that the risk reduction achievable with the US-
assisted approach is reasonably high and the NNT to prevent
major vascular complications is relatively low, supporting its
routine use during femoral vein puncture for vascular access
in EP procedures.
Our findings demonstrating benefits of the US guidance for
EP procedures are in line with the results of a previous meta-
analysis. Sobolev et al. performed an analysis of 4 trials in-
cluding a total of 4605 patients comparing US-guided femoral
vein cannulation in EP procedures to the anatomical
landmark-based technique. The US-guided femoral vein
puncture was associated with a 60% reduction of major vas-
cular bleeding and a 66% reduction of minor vascular com-
plications [11]. Since the publication of that analysis, several
observational studies were published that were allowed to
characterize the effect estimates with higher statistical power.
Moreover, we could include data from the only randomized,
controlled trial (RCT) in this field. In the multicenter, prospec-
tive ultrasound-guided femoral vein accessibility, safety and
time (ULTRA-FAST) trial, 320 patients undergoing catheter
ablation for AF were randomized to US-guided vs. conven-
tional femoral vein puncture [12]. The use of US was associ-
ated with preferable intraprocedural outcomes; however, there
was no difference in the major complication rates presumably
due to the lower-than-expected complication rate in the con-
ventional arm.
The present meta-analysis has some limitations to be ac-
knowledged. Firstly, only one randomized study was included
and the majority of data originate from observational studies.
This may introduce potential biases and/or effects of unmea-
sured confounders. In general, observational studies are more
precise but supposed to be more subject to bias. Importantly,
we found very similar outcomes in the RCT compared with
the observational studies. The lack of heterogeneity in this
aspect supports the fact that the treatment effects of the US-
guided approach are similar, independent from trial design,
and not affected by potential bias.
Important differences also may exist in patient demo-
graphics that might affect outcomes and are not accounted
for in this analysis. Use of a random-effects model can help
mitigate the potential effect of heterogeneity and the high level
of significance supports the validity of the results. Secondly,
secondary outcomes were not reported by all of the included
studies limiting further analysis of potential mechanisms.
Finally, data regarding the operators performing the puncture
and especially data on operators’ previous experience with
US-guided technique were also insufficient despite the prob-
able impact of a learning curve effect.
5 Conclusion
In conclusion, our meta-analysis including 8232 patients dem-
onstrated that real-time US-guidance of femoral vein puncture
in EP procedures is beneficial by reducing major and minor
vascular complications, inadvertent artery puncture,
postprocedural groin pain, and puncture time. These data
may substantiate recommendations for the routine use of US
in EP procedures.
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